Epidemiological evidence has shown how abdominal obesity is closely associated with the development of cardiovascular disease.It has been demonstrated that patients with extensive adipose tissue usually have other concomitant cardiovascular risk factors,such insulin resistance,hypertension and dyslipidemia.Moreover,obese patients have a significantly higher risk of developing thrombophilic events compared with the nonobese.Thus,obesity is actually considered an independent cardiovascular risk factor.The pathophysiological mechanisms responsible for the association between obesity and cardiovascular disease remain largely unknown.However,it has been postulated that obese patients have an“inflammatory milieu”responsible for their metabolic disorders and vascular disease.In this context,adipocyte-derived molecules with inflammatory activity might play a pivotal role in the development of these mechanisms.In the present report,we provide an updated overview on the molecules produced by adipose tissue that are potentially involved in cardiovascular pathophysiology.